Category: Latest News

Acurx Pharmaceuticals (NASDAQ:ACXP) reported fourth-quarter and full-year 2025 results highlighting a stronger cash position and continued progress in the development of its lead antibiotic candidate, ibezapolstat, for the treatment of Clostridioides difficile infection (C. difficile). The company said its cash balance more than doubled year over year, reaching $7.6 million as of December 31, 2025,…

Aditxt Inc. (NASDAQ:ADTX) announced it has acquired Ignite Proteomics LLC, a precision oncology company specializing in functional proteomics technology used to guide cancer treatment decisions, according to a company press release. The deal assigns Ignite a stated value of $36 million, with Aditxt issuing 36,000 shares of newly created Series A-2 Convertible Preferred Stock as…

Innovation Beverage Group Limited (NASDAQ:IBG) announced the pricing of a public offering expected to raise approximately $6 million in gross proceeds before fees and expenses, according to a company press release. The offering includes 3,428,569 units priced at $1.75 each. Each unit consists of one ordinary share or one pre-funded warrant, along with one Series…

Immutep Limited (NASDAQ:IMMP) shares plunged roughly 80% on Friday after the biotechnology company announced it would discontinue its Phase III TACTI-004 clinical trial following a futility review. The Independent Data Monitoring Committee (IDMC) recommended ending the study, which was evaluating eftilagimod alfa (“efti”) as a treatment for patients with first-line non-small cell lung cancer. After…

DevvStream Corp. (NASDAQ:DEVS) said Thursday it has completed a series of transactions that reduce its outstanding debt by approximately $5.9 million, according to a company press release. The move comes as the company works to address liquidity pressures, with its current ratio standing at 0.12 for the trailing twelve months ending Q1 2026. As part…

bioAffinity Technologies, Inc. (NASDAQ:BIAF) released its financial results for the year ended December 31, 2025, according to a statement issued Friday. The biotechnology company reported revenue of $6.2 million in 2025, representing a 34% decline from $9.4 million in 2024. The decrease was largely attributed to the company’s decision to discontinue certain unprofitable pathology services…

On March 13, 2026, ParaZero Technologies (NASDAQ:PRZO) revealed it had received a new purchase order from an Israeli defense organization for its DefendAir Counter-Unmanned Aerial Systems platform. The order covers the supply of an evaluation package that includes DefendAir net pods, as well as operational exercises and training sessions aimed at speeding up deployment and…

On March 13, 2026, Barinthus Bio (NASDAQ:BRNS) released its full-year 2025 financial results, highlighting plans for an all-stock merger with diabetes-focused Clywedog Therapeutics. The transaction, expected to close in the second quarter of 2026, would create a combined Nasdaq-listed company named Clywedog Therapeutics Holdings, Inc., with an anticipated cash runway extending into 2027. During 2025,…

U.S. consumer prices rose in line with expectations in January, according to data released Friday by the Commerce Department. The department reported that its personal consumption expenditures (PCE) price index increased 0.3% during the month, following a 0.4% rise in December. The result matched economists’ forecasts. On a yearly basis, the PCE price index rose…

Data released by the U.S. Commerce Department on Friday showed that new orders for durable goods were unchanged in January, defying expectations for an increase. According to the report, orders for long-lasting manufactured goods were essentially flat during the month after declining by a revised 0.9% in December. Economists had anticipated a 0.5% rise in…